Skip to main content

Viking Global Now Owns 17% of INBX

October 13, 2022

The largest insider transaction on today's list is a Form 4 filing by the Greenwich-based hedge fund Viking Global Investors.

The fund reported a purchase worth roughly $40 million in the small-cap biotech Inhibrx $INBX, increasing its total stake to 17%.

After just about doubling in the last two weeks, INBX is trading at its highest level since January.

Inclusive Capital’s Jeff Ubben reported the acquisition of $10 million worth of shares in Enviva $EVA in its latest Form 4.

EVA is the hedge fund’s largest holding, comprising over a third of assets under management.

EVA is the largest producer of wood pellets in the world, which are a renewable alternative to coal.

Here’s The Hot List, with data through October 12, 2022:

CEO Mahbod Nia and Director Akiva Katz both filed Form 4s reporting insider buys for a combined amount of $8 million in Veris Residential $VRE.

In the options markets, there was bullish flow in Lucid Group $LCID, U.S. Bancorp $USB, and Vodafone $VOD.

Stay tuned. We'll be back Friday with more insider action.

If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.

And please reach out with any questions. We love hearing from you!

All Star Charts Team